☆ 4.2 Review

Effects of Sheng-Mai Injection on Diabetes Mellitus: A Systematic Review and Meta-analysis

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2023)

Related references

Note: Only part of the references are listed.

Article Mathematical & Computational Biology

Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments

Luke A. McGuinness et al.

Summary: Despite the availability of numerous software options for evidence synthesis, there is currently no universal tool for generating figures to display and explore risk-of-bias assessments. However, tools such as the R programming environment and Shiny have made it easy to create new tools for producing evidence syntheses. The new tool robvis facilitates the rapid production of publication-quality risk-of-bias assessment figures and is available as an R package and web app.

RESEARCH SYNTHESIS METHODS (2021)

Add to Collection

Article Endocrinology & Metabolism

6. Glycemic Targets: Standards of Medical Care in Diabetes-2021

Summary: The ADA Standards of Medical Care in Diabetes offers recommendations and guidelines for diabetes care, with updates made by a multidisciplinary expert committee annually. Readers are invited to provide feedback on the standards through the professional website.

DIABETES CARE (2021)

Add to Collection

Article Endocrinology & Metabolism

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021

Summary: The American Diabetes Association's Standards of Medical Care in Diabetes provides clinical practice recommendations, treatment goals, guidelines, and tools for evaluating care quality. It is updated annually by a multidisciplinary expert committee, and readers are invited to comment on the standards at professional.diabetes.org/SOC.

DIABETES CARE (2021)

Add to Collection

Article Endocrinology & Metabolism

Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes

Jae-Seung Yun et al.

Summary: With advancements in diabetes care, incident cardiovascular disease in patients with type 2 diabetes mellitus has decreased. Challenges remain due to CVD being a major cause of death in diabetic patients. Research focuses on reducing cardiovascular risk in T2DM through lifestyle modifications and therapeutic approaches.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Add to Collection

Article Endocrinology & Metabolism

An Update on the Epidemiology of Type 2 Diabetes: A Global Perspective

Maria G. Tinajero et al.

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2021)

Add to Collection

Review Pharmacology & Pharmacy

Evidence and Potential Mechanisms of Jin-Gui Shen-Qi Wan as a Treatment for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

Zhipeng Hu et al.

Summary: This study analyzed 14 studies involving 1586 participants, showing that JGSQW combination therapy can reduce HbA1c, fasting blood glucose, and 2-hour postprandial glucose, but the impact on lipid metabolism remains uncertain.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Review Endocrinology & Metabolism

A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives

Josh Reed et al.

Summary: Type 2 diabetes is a metabolic disease characterized by impaired insulin secretion and action. GLP-1 mimetics, with their longer half-life, have shown to be effective in enhancing insulin secretion, alleviating post-diagnosis complications, and inducing weight loss in patients. Understanding the mechanisms of action and potential of GLP-1-based therapies can provide better insight into treating T2D effectively.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2021)

Add to Collection

Article Cell Biology

Emerging protective roles of shengmai injection in septic cardiomyopathy in mice by inducing myocardial mitochondrial autophagy via caspase-3/Beclin-1 axis

Yan Cao et al.

INFLAMMATION RESEARCH (2020)

Add to Collection

Article Endocrinology & Metabolism

Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

Pouya Saeedi et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2020)

Add to Collection

Article Medicine, General & Internal

Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study

Yongze Li et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Review Integrative & Complementary Medicine

Efficacy and Safety of Shengmai Injection for Chronic Heart Failure: A Systematic Review of Randomized Controlled Trials

Yanping Wang et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)

Add to Collection

Review Integrative & Complementary Medicine

Shengmai injection as an adjunctive therapy for the treatment of chronic obstructive pulmonary disease: A systematic review and meta-analysis

Xingyue Huang et al.

COMPLEMENTARY THERAPIES IN MEDICINE (2019)

Add to Collection

Article Endocrinology & Metabolism

The Economic Burden of Elevated Blood Glucose Levels in 2017: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes Mellitus, and Prediabetes

Timothy M. Dall et al.

DIABETES CARE (2019)

Add to Collection

Article Medicine, General & Internal

RoB 2: a revised tool for assessing risk of bias in randomised trials

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Add to Collection

Article Endocrinology & Metabolism

Economic Costs of Diabetes in the US in 2017

Wenya Yang et al.

DIABETES CARE (2018)

Add to Collection

Article Endocrinology & Metabolism

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

N. H. Cho et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2018)

Add to Collection

Review Oncology

Effects of Shengmai injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: a meta-analysis

Baoqi Duan et al.

SUPPORTIVE CARE IN CANCER (2018)

Add to Collection

Review Biochemistry & Molecular Biology

The PI3K/AKT pathway in obesity and type 2 diabetes

Xingjun Huang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)

Add to Collection

Article Chemistry, Analytical

Global analysis of chemical constituents in Shengmai injection using high performance liquid chromatography coupled with tandem mass spectrometry

Fei Li et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)

Add to Collection

Article Biochemical Research Methods

Development of a sensitive LC-MS/MS method for simultaneous quantification of eleven constituents in rat serum and its application to a pharmacokinetic study of a Chinese medicine Shengmai injection

Shuyu Zhan et al.

BIOMEDICAL CHROMATOGRAPHY (2015)

Add to Collection

Review Integrative & Complementary Medicine

Shengmai Injection, a Traditional Chinese Patent Medicine, for Intradialytic Hypotension: A Systematic Review and Meta-Analysis

Chao-yang Chen et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)

Add to Collection

Article Health Care Sciences & Services

GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology

Gordon H. Guyatt et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Add to Collection

Article Integrative & Complementary Medicine

Effect of Shengmai Injection on Vascular Endothelial and Heart Functions in Patients with Coronary Heart Disease Complicated with Diabetes Mellitus

Zhang Ya-chen et al.

CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.